Reports for TEVA-SUCRALFATE

Brand name

TEVA-SUCRALFATE

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02045702
Ingredients
SUCRALFATE
Ingredient Strength
1 G
ATC Code
A02BX
A02BX
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
TEVA-SUCRALFATE 500 Resolved 2019-08-29 2020-01-30 92663
TEVA-SUCRALFATE 100 Resolved 2020-03-26 2020-08-21 109595
TEVA-SUCRALFATE 500 Resolved 2020-07-23 2020-08-21 120890
TEVA-SUCRALFATE 500 Resolved 2020-09-24 2020-10-15 124995
TEVA-SUCRALFATE 500 Resolved 2021-04-01 2021-04-08 136759
Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports